Chimeric Therapeutics Limited

ASX:CHM Stok Raporu

Piyasa değeri: AU$8.1m

Chimeric Therapeutics Yönetim

Yönetim kriter kontrolleri 2/4

We currently do not have sufficient information about the CEO.

Anahtar bilgiler

İcra Kurulu Başkanı

n/a

Toplam tazminat

CEO maaş yüzdesin/a
CEO görev süresino data
CEO sahipliğin/a
Yönetim ortalama görev süresi2.8yrs
Yönetim Kurulu ortalama görev süresi3.2yrs

Son yönetim güncellemeleri

Recent updates

Here's Why We're Watching Chimeric Therapeutics' (ASX:CHM) Cash Burn Situation

Oct 13
Here's Why We're Watching Chimeric Therapeutics' (ASX:CHM) Cash Burn Situation

Here's Why We're Watching Chimeric Therapeutics' (ASX:CHM) Cash Burn Situation

Feb 23
Here's Why We're Watching Chimeric Therapeutics' (ASX:CHM) Cash Burn Situation

We Think Chimeric Therapeutics (ASX:CHM) Needs To Drive Business Growth Carefully

Oct 20
We Think Chimeric Therapeutics (ASX:CHM) Needs To Drive Business Growth Carefully

CEO

Chimeric Therapeutics CEO'su yok ya da onlar hakkında elimizde veri yok.


Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Paul Hopper
Founder & Executive Chairman4.8yrsAU$301.98k10.49%
A$ 855.0k
Phillip Hains
CFO, Joint Company Secretary & Director4.1yrsVeri yok1.14%
A$ 92.9k
Rebecca McQualter
Chief Operating Officerless than a yearAU$453.86kVeri yok
Jason Litten
Chief Medical Officer2.3yrsAU$1.16mVeri yok
Kelly Thornburg
VP & Head of Quality2.8yrsVeri yokVeri yok
Nathan Jong
Joint Company Secretary4.1yrsVeri yokVeri yok

2.8yrs

Ortalama Görev Süresi

63yo

Ortalama Yaş

Deneyimli Yönetim: CHM's management team is considered experienced (2.8 years average tenure).


Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Paul Hopper
Founder & Executive Chairman4.8yrsAU$301.98k10.49%
A$ 855.0k
Phillip Hains
CFO, Joint Company Secretary & Director1.3yrsVeri yok1.14%
A$ 92.9k
Larry Couture
Member of Glioblastoma Expert Advisory Boardno dataVeri yokVeri yok
Eric Sullivan
Non-Executive Director1.3yrsAU$68.78kVeri yok
Lesley Russell
Non-Executive Director4.3yrsAU$50.00k0.19%
A$ 15.7k
David Maloney
Member of Cellular Immunotherapy Scientific Advisory Board3.2yrsVeri yokVeri yok
Nader Sanai
Member of Glioblastoma Expert Advisory Boardno dataVeri yokVeri yok
Yvonne Chen
Member of Glioblastoma Expert Advisory Board3.8yrsVeri yokVeri yok
Christine Brown
Chairman of Glioblastoma Expert Advisory Boardno dataVeri yokVeri yok
Yi Lin
Member of Cellular Immunotherapy Scientific Advisory Board3.3yrsVeri yokVeri yok
Eric Smith
Member of Cellular Immunotherapy Scientific Advisory Board3.2yrsVeri yokVeri yok
Michael Bishop
Member of Cellular Immunotherapy Scientific Advisory Board3.2yrsVeri yokVeri yok

3.2yrs

Ortalama Görev Süresi

65yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: CHM's board of directors are considered experienced (3.2 years average tenure).